Premier Molecular Studies and Testing Services

Your bacterial and fungal isolates require thorough characterization to make informed decisions. Our screening algorithms help you efficiently select which isolates need molecular analysis, saving you time and resources. We analyze various sample types including isolates for resistance gene identification, DNA for sequencing analysis, RNA for expression studies, and microbiome samples for community profiling. This targeted approach means you avoid unnecessary testing costs while ensuring comprehensive coverage of your research needs.  

Get comprehensive molecular insights with our diverse testing portfolio. We provide Next Generation Sequencing (NGS) on Illumina platforms, long-read sequencing on Nanopore systems, various typing methods including MLST and O:H antigen typing, SNP analysis and genotyping, microbiome analysis through 16S amplicon sequencing, and metagenomics. Our gene expression and transcriptomics using RNA-Seq deliver the data you need. 

Our proprietary bioinformatics pipeline analyzes your sequencing data in the form of fastq files with precision, identifying resistance and virulence genes through de novo assembly of isolates. We provide multiple typing analyses for epidemiological studies, including SNP identification. Our screening algorithms help you select appropriate assays for specific resistance determinants, eliminating guess work and reducing project timelines. Our screening algorithms help you select appropriate assays for specific resistance determinants, while our detailed yet easy-to-interpret reports help you make informed decisions faster than traditional analysis approach. 

Expert support throughout your project  

From study design to final reporting, you'll work with our experienced team who understand your regulatory challenges. We assist in selecting appropriate assays, provide expert medical writing services for manuscript preparation and regulatory documentation, and help align your studies to specific GxP requirements. This hands-on partnership approach means you’re never navigating complex molecular testing alone.  

Access the latest in molecular technology without the capital investment. We utilize Illumina technology for short read sequencing (SRS) that enables accurate sequencing at high coverage depth. Our long read sequencing (LRS) on Nanopore platforms provides exceptional read length and enhanced overlap for more complete genome assembly, annotation, SNP identification, and plasmid mapping with unparalleled accuracy. This dual-platform approach gives you flexibility to choose the optimal sequencing method for each project. 

Our team operates from Life Sciences hubs across the world, providing global access to our expert capabilities. Find your nearest Life Sciences hub on our Locations Page to discuss your specific project needs.